We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sygnature Discovery Announces Multi-Target Drug Discovery Deal with Sitryx Therapeutics

News   Nov 09, 2018

 
Sygnature Discovery Announces Multi-Target Drug Discovery Deal with Sitryx Therapeutics
 
 
 

RELATED ARTICLES

Making AI Less Biased

News

With machine learning systems now being used to determine everything from stock prices to medical diagnoses, it's never been more important to look at how they arrive at decisions. A new approach out of MIT demonstrates that the main culprit is not just the algorithms themselves, but how the data itself is collected.

READ MORE

A Promising Blood Test for Early Detection of Ovarian Cancer

News

Detection of this tumor marker may also play a role in a simple liquid biopsy to monitor disease stage and treatment.

READ MORE

Fighting the Good Fight

News

Blocking an important enzyme in staphylococcal metabolism in a targeted manner would allow the pathogens to be starved.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE